Tianshui Gansu Qihuang Pharmaceutical

Gansu Qihuang Pharmaceutical Co., Ltd. is a specialized pharmaceutical enterprise located in Tianshui, Gansu Province, China, focusing on the modernization of Traditional Chinese Medicine (TCM). The company is a key subsidiary of the state-owned Gansu Pharmaceutical Group and operates as a major production base for TCM granules, capsules, and tablets in Northwest China. It gained international prominence for manufacturing Xuanfei Baidu Granules, a core TCM formulation officially recommended for the treatment of COVID-19. Beyond respiratory health, the company produces a diverse range of products derived from local medicinal herbs like Angelica sinensis (Danggui) to treat cardiovascular and gynecological conditions. Gansu Qihuang maintains advanced GMP-certified manufacturing facilities and collaborates with academic institutions to advance TCM research and standardization.